The Long War Over Gender Didn’t Begin Online

For years, the public was told that the fight over gender identity was a sudden cultural awakening: a marginal group finding its voice, a new language of identity spreading through social media, and institutions catching up with a social change they had not anticipated. That account is tidy. It is also incomplete. The more troubling picture, as researcher Mia Hughes argues, is that the machinery behind today’s gender politics was assembled long before most people had heard the term “gender-affirming care”, in medical societies, legal bodies and school systems that worked quietly while the public looked elsewhere.

What appears, from the outside, to be a rapid moral revolution was in large part a slow institutional build-out. By the time the argument entered the mainstream, the standards, the terminology and much of the professional authority were already in place.

The Public Shock Was Late, Not the Planning

The speed of the present debate has made many people assume the controversy itself is new. It is not. What is new is the level of public attention. The underlying framework took shape over decades, moving from academic theory into medical guidance, then from guidance into law and education, until the architecture was sturdy enough to survive scrutiny that would once have stopped it.

That is why so many people experienced the gender debate as a rupture. One year, the issue seemed confined to specialist journals and niche advocacy groups; the next, it was in schools, sports leagues, hospital wards and courtrooms. The scale of that jump created a false impression of spontaneous emergence. In reality, the public saw the visible phase only after the hidden phase was largely complete.

This matters because institutions rarely admit how much power they have ceded until the costs become impossible to ignore. What was sold as compassion turned into policy. What was presented as a therapeutic stance hardened into dogma. And what many assumed was a social movement was also, and perhaps more importantly, an administrative one.

John Money and the Theory That Would Not Die

The modern story begins not in the age of TikTok, but in mid-century psychiatry. At Johns Hopkins University, John Money helped establish the distinction between biological sex and psychosocial gender identity. His idea was radical for its time: that identity could be shaped by socialization and, in theory, redirected by intervention. In retrospect, it was one of those theories that sounds clinical until it reaches a child.

Money’s most notorious case involved the Reimer twins. After a botched circumcision in 1965 left Bruce Reimer without a penis, Money advised that the child be raised as a girl, renamed Brenda, and treated as proof that gender identity could be socially constructed. For a time, the case was held up as validation of Money’s theory.

It was not. Brenda never accepted the female role. The psychological damage deepened over the years, and Bruce eventually transitioned back to living as male after learning the truth. He died by suicide in 2004. His twin brother later died by suicide as well. The case should have shattered the idea that identity could be imposed by authority and reinforced by medical intervention. Instead, the theory survived the scandal.

That persistence says a great deal about how ideas endure. Bad science does not die simply because it fails. It dies when institutions that have invested in it are willing to admit they were wrong. In this case, the opposite happened. Money’s distinction between sex and gender remained useful to academics, activists, and professionals looking for a framework that separated identity from biology. The details of the case became embarrassing; the theory, stripped of its most brutal consequences, continued to travel.

How a Rare Condition Became an Administrative Category

Once the theory existed, the rest of the process followed a familiar institutional pattern. A concept that began as a medical curiosity became a treatment pathway, then a professional standard, then a political category. The key vehicle was the World Professional Association for Transgender Health, originally founded in 1979 as the Harry Benjamin International Gender Dysphoria Association.

Its early standards were cautious, aimed at a small number of adults with persistent gender dysphoria. But caution is not a permanent state in a profession under ideological pressure. Over time, the organisation and related bodies drifted from a narrow clinical model toward a broader affirmation model. Gender dysphoria, once treated as a psychiatric condition requiring careful scrutiny, was increasingly recast as a stable identity that deserved recognition rather than interrogation.

That shift changed everything. If a person is a patient, then the clinician asks what is causing distress. If the person is already assumed to possess a fixed identity, the clinician is told to affirm. The difference is not semantic. It determines whether medicine is used to investigate a problem or to ratify a belief.

The change also had a legal afterlife. The DSM-5 in 2013 replaced “gender identity disorder” with “gender dysphoria,” moving the focus from identity itself to distress. The ICD-11 later shifted related categories out of mental disorders and into sexual health. Advocates presented this as a humane correction to stigma. Critics saw something else: a way of preserving medical access while launderising a contested theory through softer language.

The language mattered because language became policy. Once “gender identity” was treated as a settled fact rather than a theory under debate, the argument was no longer about whether the framework was right. It was about how quickly the rest of society had to comply.

The Numbers That Made the Old Story Hard to Believe

If the movement were merely a matter of long-suppressed identities finally becoming visible, the numbers would have to make sense. They do not, at least not in the simple way advocates often suggest. Historically, severe cases of gender dysphoria were rare. Then, over a relatively short period, referrals and diagnoses surged across Western countries at a rate that looked less like demographic drift than social contagion.

In the United Kingdom, referrals to the Gender Identity Development Service rose from roughly 250 a year before the 2010s to more than 5,000 by 2021 and 2022. That alone would have been notable. What made it impossible to dismiss was the demographic shift inside the surge. Adolescent girls, once a minority in the clinic population, became the dominant group. Similar patterns were reported elsewhere: sharp increases, often many times over baseline, concentrated among teenage females.

The United States showed the same rough contour. Youth diagnoses tripled from about 15,000 to 42,000 between 2017 and 2021. Again, the point is not that every case is illegitimate. The point is that the curve itself demands explanation. If a condition expands suddenly, in one demographic, across many countries, in the same era of social media, the honest response is not to say “nothing to see here”. It is to ask what changed.

The answer is not simple. Some of the rise may reflect better recognition, greater willingness to seek help, and reduced stigma. But those factors do not explain the entire pattern, especially when the historical picture was one of far lower prevalence and much more stable sex ratios. When one group suddenly dominates the caseload, and when the increase occurs in step with online peer communities and identity-focused subcultures, it becomes difficult to maintain the fantasy of purely organic change.

The numbers do not prove a single cause. They do, however, demolish the assumption that the current wave is identical to the small, longstanding population of adults who experienced persistent dysphoria in earlier decades.

What the Leaked WPATH Documents Suggested in Private

Mia Hughes’s book, The WPATH Files, takes the debate into the room many advocates did not want opened: the gap between public certainty and private uncertainty. The leaked internal documents she examined suggest a profession speaking with one voice in public while wrestling with doubts in private.

That gap matters more than any one memo. Medical bodies have no moral authority if they project consensus while internally acknowledging weak evidence. Yet that is close to what the documents appear to show. They suggest professionals discussing experimental treatments for minors while treating the ethical questions as settled, working through consent problems with adolescents, and confronting the limits of evidence only where the public could not see.

The internal WPATH review of cross-sex hormones, as described in Hughes’s account, found insufficient evidence for safety and efficacy. But the standards of care did not reflect that caution. The organisation kept recommending the treatment path anyway. That is not how a serious medical body behaves when the evidence is uncertain. It is how an advocacy institution behaves when the desired policy has already been chosen.

The documents also point to a deeper institutional habit: the conversion of dissent into moral failure. Questions about detransition, long-term outcomes or comorbid mental health issues were not merely unanswered. They were often treated as threats to the project. In that environment, “affirmation” ceased to mean compassion and began to mean obedience.

This is the part that should unsettle anyone who trusts professional authority. There was no need for a grand conspiracy in the cinematic sense. The documents suggest something more ordinary and therefore more dangerous: people inside a respected body came to believe the cause they served justified the shortcuts they took. Once that happens, the institution no longer corrects ideology. It institutionalises it.

Law and Schooling Turned an Idea into a Regime

Medicine did not carry this alone. The modern gender framework spread because law and education helped carry it. That is the real trick of ideological capture: once an idea has been written into policy and repeated in classrooms, it no longer needs to persuade people. It only needs to appear inevitable.

In law, rights commissions, tribunals and regulatory bodies became crucial. These institutions often operate outside the ordinary glare of electoral politics. They do not need a national majority to keep moving. They need only enough procedural authority to translate a contested claim into a binding norm. Once gender identity was folded into anti-discrimination language, the issue stopped being merely a public argument. It became a compliance problem.

This mattered particularly where speech was concerned. If a tribunal or commission decides that certain language is discriminatory, then disagreement is no longer disagreement. It is liability. That shift changes the tone of every debate that follows. Parents, teachers, employers and journalists begin to calculate risk before they speak. The result is not persuasion but caution, and caution is often mistaken for consent.

Schools were even more important. If you want to normalize a doctrine, start with children. Curriculum changes, teacher training and “inclusive” materials reached students long before most parents realized what had been introduced. By the time public controversy erupted over bathrooms, sports or pronouns, the assumption that gender identity was settled truth had already been smuggled into the educational bloodstream.

The brilliance of this strategy lay in its ordinary appearance. It did not arrive with banners or police escorts. It came as training, safeguarding, sensitivity and updated policy. That is how a controversial idea becomes the default. It moves through systems that trust their own moral vocabulary and do not notice that the vocabulary is doing more than describing the world. It is remaking it.

The Human Cost of Calling Doubt Harm

Every institutional movement eventually meets the people it has damaged. In the gender debate, those people are increasingly visible in the growing ranks of detransitioners, many of whom describe being rushed into medical pathways that did not fully examine what else might have been going on in their lives.

Their accounts are not all the same, and they should not be flattened into a single script. But the themes recur. They describe inadequate screening for autism, trauma, depression or anxiety. They describe conversations in which puberty blockers, hormones or surgery were presented as the obvious answer rather than one possibility among many. They describe parents whose concerns were treated as prejudice. And they describe a clinic culture in which asking questions was itself treated as transphobia.

That is the ethical failure at the center of the issue. Medicine is supposed to slow things down when the stakes are high. In this case, the ideological pressure to affirm often did the opposite. It compressed time. It reduced uncertainty. It turned the refusal to explore alternatives into a virtue.

The result is not abstract. It is bodies that cannot be restored, fertility that may be damaged, and young people who later discover that the treatment they were told would solve their distress did not, in fact, solve it. Some may remain content with their choices. Others will not. The existence of the second group should be enough to force caution, yet for years it was easier in some circles to pretend that regret barely existed.

That pretense is collapsing. Lawsuits are mounting. Public testimony from detransitioners has become harder to dismiss. And the more these stories surface, the less credible it becomes to describe the whole field as settled science. If a medical movement produces a body of injured former patients who were once told they were its success stories, then something has gone badly wrong in the system that crowned itself compassionate.

The Cass Review and Europe’s Slow Retreat

One of the most important developments in the debate has not come from the United States, where the argument is most theatrical, but from Europe, where several health systems have quietly moved in a different direction. That should matter. Policy reversals are not proof of bad faith, but they are a strong sign that the evidence never justified the confidence that accompanied it.

The UK’s Cass Review, commissioned by NHS England and published in 2024, is the clearest example. Its conclusion was not a full-throated denunciation of gender medicine. It was, if anything, more damning than that: a bureaucratic verdict that the evidence base was too weak to sustain routine medicalization of children and adolescents. The review described the evidence for puberty blockers and cross-sex hormones as “remarkably weak”, found poor-quality studies and questioned the assumption that more medical intervention produced better mental health outcomes.

The significance of that sentence should not be missed. “Remarkably weak” is not language used for a field with a mature evidence base. It is language used when the profession has outrun the data.

Other countries reached similar conclusions. Sweden, Finland and Norway all tightened their policies, putting psychological assessment ahead of routine medical pathways and restricting some treatments to research settings or exceptional circumstances. That does not end the debate, but it does puncture the idea that caution is somehow extremist. In practice, many of the most advanced European health systems are now telling a more careful story than the one that dominated activist discourse for years.

The contrast with the American debate is telling. In the United States, the argument has often been cast as a culture war between enlightened care and cruelty. In Europe, the same issue has increasingly been treated as a question of evidence, risk and long-term uncertainty. That difference is not cosmetic. It is a measure of how much institutional entrenchment can distort the meaning of compassion.

The Idea Survived Because It Became Useful

A weak theory does not spread on merit alone. It survives because it becomes useful to the people who control institutions. That is the lesson running through this entire history. John Money’s framework proved useful to academics who wanted a cleaner distinction between sex and identity. WPATH’s standards proved useful to clinicians who wanted a stable professional language. Legal bodies found the framework useful for extending anti-discrimination rules into new terrain. Schools found it useful for presenting contested claims as settled truth.

The point is not that every actor involved was cynical. Many were probably sincere. Sincerity, however, is not a defence against bad outcomes. Some of the most damaging institutions in modern life are staffed by people who believe they are doing good.

That is why Hughes’s larger argument lands where it does. She does not need to prove a secret master plan to show that a movement can be built by overlapping incentives, shared assumptions and institutional laziness. If enough people in medicine, law and education decide the same thing is morally urgent, then the public may not notice the change until the change is hard to reverse.

That is exactly what happened here. The movement’s public language emphasised liberation, dignity and inclusion. Its private method was more prosaic: capture the standards, secure the terminology, control the gatekeepers, and treat dissent as an ethical defect. Once those steps were in place, the public was handed a finished product and told the debate was over.

It was not over. It had barely begun.

What the Public Is Owed Now

The central question is no longer whether gender identity exists. People experience their bodies and identities in ways that can be complicated, painful, and deeply personal. The real question is whether the institutions built around those experiences can admit that they moved too fast, asked too few hard questions, and treated uncertainty as a public-relations problem.

Children and adolescents deserve more than a ritual of affirmation. They deserve careful assessment, honest explanation, and time. Parents deserve access to the full range of debate, not a scripted consensus delivered by institutions that cannot tolerate dissent. Detransitioners deserve to be heard without being used as props by either side. And the public deserves a medical system that remembers the difference between compassion and haste.

Personally, what evades is the reasoning that prioritizes arguing for children (UN defines anyone under 18 as a child) to have irreversible hormone treatment and even, in the extreme, surgery, all in an effort to affirm gender dysphoria. For me, this is puzzling as to why people are eager to make getting an abortion easier than visiting the dentist about oral hygiene. Even if we allow these treatments as a right, the medical profession should push back rather than just fold in front of progressive ideology.

This is where the current story finally becomes hard to evade. A movement that presented itself as a response to newly visible people also appears to have relied on decades of institutional preparation, a failed intellectual inheritance, and a willingness to enforce certainty before the evidence was in. That combination is how a bad idea becomes policy.

The argument over gender will not be settled by slogans, social-media pile-ons or the easy habit of calling skeptics bigots. It will be settled, if it is settled at all, by whether the institutions that carried this framework into law, medicine, and schooling can now withstand the plain question they spent years avoiding: what, exactly, was built here, and at what cost?